Abstract
The study was conducted to determine the levels of usage of complementary and integrative health (CIH) approaches and the symptoms experienced by Turkish patients with gastrointestinal cancer. A descriptive study was conducted on 81 patients with gastrointestinal cancer attending the medical oncology department of an oncology hospital. In the data collection stage, the patient description form that prepared by the researchers and the “Edmonton Symptom Assessment Scale” were used. Data were evaluated via Chi-square and student t test. It was determined that 55.6% of the patients with gastrointestinal cancer applied at least one CIH approaches, and these CIH approaches were praying (80.0%), herbal medicine (57.7%), a special diet (40.0%), therapeutic touch (15.6%), exercise (13.3%) and psychotherapy (4.4%). 68.8% of patients who used the CIH approach stated that they applied the CIH approaches in order to supplement the medical treatment, and 91.1% stated that they did not inform health employees about that they using the CIH approach. It was also found that the use of CIH approaches was not related to socio-demographic characteristics, disease characteristics and experienced symptoms. It is very important that patients with gastrointestinal cancer be questioned in terms of CIH approaches used.
Similar content being viewed by others
References
Akyol, A. D., & Oz, B. (2011). The use of complementary and alternative medicine by patients with cancer: In Turkey. Complementary Therapies in Clinical Practice., 17(4), 230–234. https://doi.org/10.1016/j.ctcp.2010.12.003.
Akyol, A. D., Yildirim, Y., Toker, E., & Yavuz, B. (2011). The use of complementary and alternative medicine among chronic renal failure patients. Journal of Clinical Nursing, 20(7–8), 1035–1043. https://doi.org/10.1111/j.1365-2702.2010.03498.x.
Algier, L. A., Hanoglu, Z., Ozden, G., & Kara, F. (2005). The use of complementary and alternative (non-conventional) medicine in cancer patients in Turkey. European Journal of Oncology Nursing, 9(2), 138–146.
Alhaj, N. H., Shamsudin, M. N., Alipiah, N. M., & Zamri, H. F. (2010). Characterization of Nigella Sativa L. essential oil-loaded solid lipid nanoparticles. American Journal of Pharmacology and Toxicology, 5(1), 52–57.
Aydin-Avci, I., Koç, Z., & Sağlam, Z. (2012). Use of complementary and alternative medicine by patients with cancer in northern Turkey: Analysis of cost and satisfaction. Journal of Clinical Nursing, 21(5–6), 677–688. https://doi.org/10.1111/j.1365-2702.2011.03732.x.
Bao, Y., Kong, X., Yang, L., Liu, R., Shi, Z., Li, W., et al. (2014). Complementary and alternative medicine for cancer pain: An overview of systematic reviews. Evidence-Based Complementary and Alternative Medicine, 2014, 170396. https://doi.org/10.1155/2014/170396.
Bismark, R. S., Chen, H., Dy, G. K., Gage-Bouchard, E. A., & Mahoney, M. C. (2014). Complementary and alternative medicine use among patients with thoracic malignancies. Supportive Care in Cancer, 22(7), 1857–1866. https://doi.org/10.1007/s00520-014-2144-0.
Bjelakovic, G., Nikolova, D., Simonetti, R. G., & Gluud, C. (2008). Antioxidant supplements for preventing gastrointestinal cancers. Cochrane Database of Systematic Reviews, (3), CD004183. https://doi.org/10.1002/14651858.cd004183.pub3.
Bruera, E., Kuehn, N., Miller, M. J., Selmser, P., & Macmillan, K. (1991). The Edmonton Symptom Assessment System (ESAS): A simple method for the assessment of palliative care patients. Journal of Palliative Care, 7(2), 6–9.
Can, G., Erol, O., Aydiner, A., & Topuz, E. (2009). Quality of life and complementary and alternative medicine use among cancer patients in Turkey. European Journal of Oncology Nursing, 13(4), 287–294. https://doi.org/10.1016/j.ejon.2009.03.007.
Conrad, A. C., Muenstedt, K., Micke, O., Prott, F. J., Muecke, R., & Huebner, J. (2014). Attitudes of members of the German Society for Palliative Medicine toward complementary and alternative medicine for cancer patients. Journal of Cancer Research Clinical Oncology, 140(7), 1229–1237. https://doi.org/10.1007/s00432-014-1656-9.
Dai, Z. J., Shao, Y. P., Kang, H. F., Tang, W., Xu, D., Zhao, Y., et al. (2015). Relationship between apurinic endonuclease 1 Asp148Glu polymorphism and gastrointestinal cancer risk: An updated meta-analysis. World Journal of Gastroenterology, 21(16), 5081–5089. https://doi.org/10.3748/wjg.v21.i16.5081.
Ezeome, E. R., & Anarado, A. N. (2007). Use of complementary and alternative medicine by cancer patients at the University of Nigeria Teaching Hospital, Enugu, Nigeria. BMC Complementary and Alternative Medicine, 7, 28. https://doi.org/10.1186/1472-6882-7-28.
Gürdil-Yilmaz, S., Opak-Yücel, B., & Çuhadar, D. (2017). Knowledge and attitudes of the faculty of theology students on organ transplantation. Journal of Religion and Health, 56(3), 1042–1051. https://doi.org/10.1007/s10943-016-0351-3.
Haq, S., Ali, S., Mohammad, R., & Sarkar, F. H. (2012). The complexities of epidemiology and prevention of gastrointestinal cancers. International Journal of Molecular Sciences, 13(10), 12556–12572. https://doi.org/10.3390/ijms131012556.
Kalender, M. E., Buyukhatipoglu, H., Balakan, O., Suner, A., Dirier, A., Sevinc, A., et al. (2014). Depression, anxiety and quality of life through the use of complementary and alternative medicine among breast cancer patients in Turkey. Journal of Cancer Research and Therapeutics, 10(4), 962–966. https://doi.org/10.4103/0973-1482.138010.
Kav, T. (2009). Use of complementary and alternative medicine: A survey in Turkish gastroenterology patients. BMC Complementary Alternative Medicine, 9, 41. https://doi.org/10.1186/1472-6882-9-41.
Kong, S. C., Hurlstone, D. P., Pocock, C. Y., Walkington, L. A., Farquharson, N. R., Bramble, M. G., et al. (2005). The incidence of self-prescribed oral complementary and alternative medicine use by patients with gastrointestinal diseases. Journal of Clinical Gastroenterology, 39(2), 138–141.
Kucukoner, M., Bilge, Z., Isıkdogan, A., Kaplan, M. A., Inal, A., & Urakci, Z. (2013). Complementary and alternative medicine usage in cancer patients in southeast of Turkey. African Journal of Traditional Complementary Alternative Medicine, 10(1), 21–25. https://doi.org/10.4314/ajtcam.v10i1.4.
Lawsin, C., DuHamel, K., Itzkowitz, S. H., Brown, K., Lim, H., Thelemaque, L., et al. (2007). Demographic, medical, and psychosocial correlates to CAM use among survivors of colorectal cancer. Supportive Care in Cancer, 15(5), 557–564. https://doi.org/10.1007/s00432-014-1656-9.
National Center for Complementary and Integrative Health. (2016). Complementary, alternative, or integrative health: What’s in a name? Retrieved from https://nccih.nih.gov.
Paiva, C. E., Manfredini, L. L., Paiva, B. S., Hui, D., & Bruera, E. (2015). The Brazilian Version of the Edmonton Symptom Assessment System (ESAS) is a feasible, valid and reliable instrument for the measurement of symptoms in advanced cancer patients. PLoS ONE, 7, e0132073. https://doi.org/10.1371/journal.pone.0132073.
Paltiel, O., Avitzour, M., Peretz, T., Cherny, N., Kaduri, L., Pfeffer, R. M., et al. (2001). Determinants of the use of complementary therapies by patients with cancer. Journal of Clinical Oncology, 19(9), 2439–2448.
Sadırlı-Kurt, S., & Ünsar, S. (2009). Edmonton symptom assessment scale for patients with cancer: Its validity and reliability in Turkish. Journal of Firat Health Services, 4(11), 79–94. [Kanserli Hastalarda Edmonton Semptom Tanılama Ölçeği (ESTÖ): Türkçe Geçerlilik ve Güvenirlik Çalışması. Fırat Sağlık Hizmetleri Dergisi,] Article in Turkish.
Siegel, R. L., Miller, K. D., & Jemal, A. (2017). Cancer statistics 2017. CA Cancer Journal For Clinicians, 67(1), 7–30. https://doi.org/10.3322/caac.21387.
Tuna, S., Dizdar, O., & Calis, M. (2013). The prevalence of usage of herbal medicines among cancer patients. J BUON, 18(4), 1048–1051.
Ucan, O., Pehlivan, S., Ovayolu, N., Sevinc, A., & Camci, C. (2008). The use of complementary therapies in cancer patients: A questionnaire-based descriptive survey from southeastern Turkey. American Journal of Clinical Oncology, 31, 589–594. https://doi.org/10.1097/COC.0b013e31817700cc.
Yan, H., & Sellick, K. (2004a). Symptoms, psychological distress, social support, and quality of life of Chinese patients newly diagnosed with gastrointestinal cancer. Cancer Nursing, 27(5), 389–399.
Yan, H., & Sellick, K. (2004b). Quality of life of Chinese patients newly diagnosed with gastrointestinal cancer: A longitudinal study. International Journal of Nursing Studies, 41(3), 309–319.
Yildiz, I., Ozguroglu, M., Toptas, T., Turna, H., Sen, F., & Yildiz, M. (2013). Patterns of complementary and alternative medicine use among Turkish cancer patients. Journal of Palliative Medicine, 16(4), 383–390.
Yıldırım, Y. (2010). Patterns of the complementary and alternative medicine in women with metastatic cancer. Cancer Nursing, 33(3), 194–200. https://doi.org/10.1097/NCC.0b013e3181c295ac.
Acknowledgements
We thank all of our patients participated in the study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interests
The authors declare that they have no conflict of interest.
Ethical Approval
Ethics committee approval was received for this study. All procedures performed in the study were in accordance with the ethical standards of university ethics committee.
Informed Consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Pehlivan, S., Süner, A., Yıldırım, Y. et al. Investigation into Complementary and Integrative Health Approaches for Turkish Patients with Gastrointestinal Cancer. J Relig Health 57, 1497–1508 (2018). https://doi.org/10.1007/s10943-017-0546-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10943-017-0546-2